SCHEMBL502054

SCHEMBL502054

NNOC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2558345 0.96
SCHEMBL31556471 0.83 CYP1A2 (0.32)
SCHEMBL1312664 0.62
SCHEMBL2163069 0.61
SCHEMBL27677388 0.61
SCHEMBL845389 0.61
SCHEMBL9472108 0.61
SCHEMBL17450861 0.61
SCHEMBL11112607 0.60
SCHEMBL15541274 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 898 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118772068-A Preparation method of deuterated methyl uric acid standard substance 上海原思标物科技有限公司 2024-10-15 CN claimed
CN-118475661-A Hydrazinoformate functional compounds PPG工业俄亥俄公司 2024-08-09 CN claimed
CN-118359605-A Fluorescent probe, preparation method thereof and application thereof in cobalt ion detection 北京印刷学院 2024-07-19 CN claimed
CN-114728019-B Allophanate activated polyvinyl alcohol (PVAC) as a polymer-based antitumor agent 克里梅德(公开)有限公司 2024-07-02 CN claimed
US-20240197633-A1 PEGYLATED LIPID, LIPOSOME MODIFIED BY THE LIPID, PHARMACEUTICAL COMPOSITION CONTAINING THE LIPOSOME, FORMULATION AND APPLICATION THEREOF XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2024-06-20 US claimed
US-20240180951-A1 PEGYLATED LIPID, LIPOSOME MODIFIED BY THE LIPID, PHARMACEUTICAL COMPOSITION CONTAINING THE LIPOSOME, FORMULATION AND APPLICATION THEREOF XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2024-06-06 US claimed
CN-118126275-A Polyoxymethylene with good flow uniformity and preparation method thereof 开滦(集团)有限责任公司 2024-06-04 CN claimed
CN-115058727-B Surface modification method for proton exchange membrane electrolysis Chi Taiji bipolar plate 北京科技大学 2024-03-29 CN claimed
EP-4321504-A1 PEGYLATED LIPID AND LIPOSOME MODIFIED THEREBY, AND PHARMACEUTICAL COMPOSITION COMPRISING LIPOSOME AND PREPARATION AND USE THEREOF Xiamen Sinopeg Biotech Co., Ltd. (CN) 2024-02-14 EP claimed
EP-4321503-A1 PEGYLATED LIPID, LIPOSOME MODIFIED THEREBY, PHARMACEUTICAL COMPOSITION CONTAINING LIPOSOME, PREPARATION THEREOF, AND USE THEREOF Xiamen Sinopeg Biotech Co., Ltd. (CN) 2024-02-14 EP claimed
CN-101400680-A Spiroindolinone derivatives HOFFMANN LA ROCHE (CH) 2009-04-01 CN claimed
CN-101142249-A Unstable terminal group decomposition treating agent, stabilized polyacetal resin using same, production method, composition, and molded article POLYPLASTICS CO (JP) 2008-03-12 CN claimed
CN-101085793-A Helicid new medicine containing 1,3,4-oxdiazole heterocycle with sedative activity and preparing method thereof UNIV SICHUAN (CN) 2007-12-12 CN claimed
CN-101080280-A Cobalt and nickel electroless plating in microelectronic devices ENTHONE (US) 2007-11-28 CN claimed
CN-1807419-A 1,2,4-triazole [4,3-alpha] chinoline -1-one derivative as antiepileptics medicine and its pharmaceutical salts QUAN ZHESHAN (CN) 2006-07-26 CN claimed
US-6413785-B1 FORMING RESIN-BOUND, N-PROTECTED ALPHA-HYDRAZINYL ESTER; FORMING IMINE; THEN FORMING SECONDARY UREA; THEN PREPARING COMPOUND BY REMOVING SECONDARY UREA FROM RESIN AND CYCLIZING IT THE PROCTER & GAMBLE CO. 2002-07-02 US claimed
JP-2002503725-A 2002-02-05 JP claimed
EP-1056726-A1 SOLID PHASE SYNTHESIS OF 1-AMINOHYDANTOINS THE PROCTER & GAMBLE COMPANY (US) 2000-12-06 EP claimed
WO-1999042450-A1 SOLID PHASE SYNTHESIS OF 1-AMINOHYDANTOINS THE PROCTER & GAMBLE COMPANY (US) 1999-08-26 WO claimed
CN-88101660-A Preparation method of 4- [4- [4- [4- [ [2- (2, 4-difluorophenyl) -2- (1H-azolylmethyl) -1, 3-dioxolane-4-yl ] methoxy ] phenyl ] -1-piperazinylbutylphenyl butanetriazolones 1988-11-09 CN claimed